Cellulitis and acute lymphangitis of face
ICD-10 L03.21 is a used to indicate a diagnosis of cellulitis and acute lymphangitis of face.
L03.21 refers to cellulitis and acute lymphangitis of the face, a condition characterized by inflammation of the skin and subcutaneous tissues, often resulting from bacterial infection. Clinically, patients may present with symptoms such as redness, swelling, warmth, and pain localized to the facial area, often accompanied by systemic symptoms like fever and malaise. The anatomy involved includes the dermis and subcutaneous fat, with lymphatic vessels potentially affected, leading to lymphangitis. Disease progression can vary; if untreated, cellulitis may lead to abscess formation or systemic infection. Diagnostic considerations include a thorough clinical examination and may involve imaging studies if complications are suspected. Laboratory tests such as blood cultures may be warranted in severe cases to identify the causative organism. Prompt diagnosis and treatment are crucial to prevent complications and ensure optimal patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L03.21 specifically covers cellulitis and acute lymphangitis localized to the face, typically caused by bacterial infections such as Streptococcus or Staphylococcus species. It is characterized by inflammation, swelling, and potential systemic symptoms.
L03.21 should be used when the cellulitis is specifically located on the face and is accompanied by acute lymphangitis. It is important to differentiate from other cellulitis codes that do not specify the location or associated conditions.
Documentation should include a detailed clinical assessment, noting the location and extent of the cellulitis, any systemic symptoms, treatment provided, and response to therapy. Laboratory results and imaging studies, if performed, should also be included.
